KARVEZIDE
150MG/12,5MG TBL NOB 14
| SÚKL code | 0025823 |
|---|---|
| Name of the product | KARVEZIDE |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | KARVEZIDE |
| Supplement | 150MG/12,5MG TBL NOB 14 |
| Strenght | 150MG/12,5MG |
| Pharmaceutical form | Tablet |
| Package | 14 |
| Route | Oral use |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance |
HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDUM) IRBESARTAN (IRBESARTANUM) |
| ATC group | C09DA04 |
| ATC group name | IRBESARTAN A DIURETIKA |
| Doping | Diuretika a maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz www.antidoping.cz/cs/zakazane-leky |
Marketing authorisation information
| Registration Number | EU/1/98/085/007 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Sanofi Winthrop Industrie, Gentilly |
| MA Holder country | FRANCIE |
cz